(2E)-N-(3,4-Difluorophenyl)-3-[4-(2-methylpropyl)phenyl]prop-2-enamide

Catalog No.: 
ACKTIN267
CAS No.: 
329778-54-3
Molecular Formula: 
C19H19F2NO
Molecular Weight: 
315.36
(2E)-N-(3,4-Difluorophenyl)-3-[4-(2-methylpropyl)phenyl]prop-2-enamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$94.00InquiryInquiry
1g90%$290.00InquiryInquiry
5g90%$1421.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2E)-N-(3,4-Difluorophenyl)-3-[4-(2-methylpropyl)phenyl]prop-2-enamide
IUPAC Name(E)-N-(3,4-difluorophenyl)-3-(4-isobutylphenyl)acrylamide
MDL No.MFCD01784495
Molecular FormulaC19H19F2NO
Molecular Weight315.36
SMILESO=C(NC1=CC=C(F)C(F)=C1)/C=C/C2=CC=C(CC(C)C)C=C2
InChI KeySNYXOECLSPZIND-JXMROGBWSA-N
Synonym(2E)-N-(3,4-difluorophenyl)-3-[4-(2-methylpropyl)phenyl]prop-2-enamide;2-Propenamide, N-(3,4-difluorophenyl)-3-[4-(2-methylpropyl)phenyl]-;N-(3,4-DIFLUORO-PHENYL)-3-(4-ISOBUTYL-PHENYL)-ACRYLAMIDE
CAS No.329778-54-3

Synthetic Route by SureRoute

1. ACKTIN267 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRBGE701 route compound structure diagram
    ACRBGE70110117-64-3In Stock
  4. Then
  5. ACKTIN267 route product structure diagram
    ACKTIN267329778-54-3
Inquiry

2. ACKTIN267 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRBGE701 route compound structure diagram
    ACRBGE70110117-64-3In Stock
  4. Then
  5. ACKTIN267 route product structure diagram
    ACKTIN267329778-54-3
Inquiry

3. ACKTIN267 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKTIN267 route product structure diagram
    ACKTIN267329778-54-3
Inquiry

Comments (0)